Aug 19, 2022, 09:55 by

Aug 18, 2022, 10:13 by

Aug 18, 2022, 10:11 by

BioAgilytix Labs, LLC (BioAgilytix), a leading contract research organization supporting pharmaceutical and biotech partners in all phases of drug development, has announced the appointment of Dr. Linda Robbie as Chief Operating Officer. This appointment was effective as of August 9th, 2022.

Aug 18, 2022, 01:00 by User Not Found

Clinical Research News | A research team is advocating for a more data-driven approach to Alzheimer’s research where sets of biological pathways get grouped with mechanisms the body itself uses to ward off the disease.

Aug 17, 2022, 09:21 by

Jumo Health, a global provider of age appropriate, culturally sensitive medical education resources, today announced it is among the fastest growing private companies as reported by Inc. Magazine in its prestigious Inc. 5000 list.

Aug 16, 2022, 09:22 by

Aug 16, 2022, 09:22 by

Saama announces appointment of life science industry sales and marketing expert A.J. Mills as company's Chief Commercial Officer.

Aug 16, 2022, 01:00 by User Not Found

Clinical Research News | Evidence is emerging that long COVID (formally “post-acute sequelae SARS-CoV-2 infection,” or PASC) bears a striking, molecular-level resemblance to the disabling and complex illness now known as myalgic encephalomyelitis/chronic fatigue syndrome.

Aug 15, 2022, 10:17 by

Saama announces multi-year agreement with Merck to leverage Saama's Life Science Analytics Cloud (LSAC) to build new clinical data layer to strengthen Merck’s clinical development capabilities and expedite pipeline progress.

Aug 12, 2022, 10:11 by

“COLLABORATION, INNOVATION AND ENHANCING QUALITY IN CLINICAL TRIALS” Virtual Conference and Expo

Aug 12, 2022, 10:10 by

Alliance Pharma today announced they will be opening a bioanalytical laboratory, Alliance Pharma Pty, Ltd., in Brisbane, Australia.

Aug 12, 2022, 01:00 by User Not Found

Clinical Research News | Large biopharma companies use two outsourcing models to deliver their clinical trial portfolios: CRO and FSP. But what about mid-sized companies? As they experience significant growth in development, have their operating models grown with them?

Aug 11, 2022, 01:00 by User Not Found

Clinical Research News | A multi-national team of clinicians and scientists has determined that the consensus molecular subtype (CMS) classification of colorectal cancer needs updating to better reflect the molecular underpinnings of the disease.

Aug 10, 2022, 09:42 by

The researchers concluded that automated analysis of EEG data is a promising way to stratify patients and track disease progression, while enabling better patient selection for clinical trials.

Aug 10, 2022, 09:40 by

Aug 10, 2022, 01:00 by User Not Found

Clinical Research News | The International Organization for Standardization (ISO) has published Phenopackets, a standard initially developed by the Global Alliance for Genomics and Health and championed at ISO under the Canadian Mirror Committee to ISO/TC215/SC1 Genomics informatics, and supported by the Standards Council of Canada.

Aug 9, 2022, 10:36 by

Trial sponsors rely on Calyx IRT to ensure patient supply during rare disease treatment development

Aug 9, 2022, 01:00 by User Not Found

Clinical Research News | Researchers in Germany have developed a web-based tool, powered by machine learning, which extracts disease subtypes from large pools of patient data. The goal is more precise and robust predictions about molecular signatures that can serve as a starting point for investigating disease heterogeneity.

Aug 8, 2022, 10:20 by

Signant Health, the leader in evidence generation for modern clinical trials, announced a partnership with Loftware to offer customers integrated clinical trial supply labeling and packaging capabilities. Loftware is the leading provider of labeling and regulated content solutions and can now be integrated with Signant’s SmartSignals™ Supplies solutions to provide customers with a seamless product label design, approval, and production process.

Aug 8, 2022, 10:20 by

Cypex’s recombinant xenobiotic metabolizing enzymes complement BioIVT’s extensive portfolio of hepatocytes and related hepatic products for drug research and development.